FDA approves GTC's goat-based drug Atryn
Friday, February 6, 2009 - 13:07
in Health & Medicine
WASHINGTON (Reuters) - The U.S. Food and Drug Administration has approved GTC Biotherapeutics Inc's experimental anti-clotting therapy called Atryn, an FDA spokeswoman said on Friday.